Patiromer for the management of hyperkalemia in subjects receiving renin-angiotensin-aldosterone system inhibitor medications for heart failure with reduced ejection fraction

22 May 2022 (11:25 - 11:37)
Organised by:
Congress Presentation Part of: Late-Breaking Trials - Pharmacological treatment I Heart Failure with Reduced Ejection Fraction (HFrEF) HFA Premium Access Heart Failure 2022

ESC 365 is supported by

ESC 365 is supported by